SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Non-Executive Directorate Changes

28 Sep 2015 07:00

RNS Number : 3008A
Origin Enterprises Plc
28 September 2015
 



 

 

 

Origin Enterprises plc - Non-Executive Directorate Changes

 

Origin Enterprises plc ("Origin") announces the appointment of two new Non-Executive Directors. Ms. Kate Allum and Dr. Christopher Richards will be appointed to the Board with effect from 1 October 2015 along with Mr. Gary Britton and Ms. Rose Hynes whose appointments were announced on 23 September 2015.

Ms. Kate Allum is currently a Non-Executive Director at Cranswick plc where she is a member of both the Audit and the Remuneration and Nomination Committee. She has also previously held a number of senior roles in the food and agricultural sector, including Chief Executive of First Milk Limited and Head of European Supply Chain for McDonald's Restaurants.

Dr. Christopher Richards has more than 30 years international experience in the agriculture industry and currently farms in the West of England. He is Chairman of Plant Health Care plc, a Non-Executive Director of Dechra Pharmaceuticals plc where he also chairs the Remuneration Committee, and a Non-Executive Director of Cibus Global. Chris previously spent 20 years in various leadership roles with Syngenta and its predecessor companies before serving as CEO and, later, Non-Executive Chairman of Arysta LifeScience. Chris holds an MA in Zoology and a D. Phil. in Ecology from Oxford University and was previously a researcher with the Ministry of Agriculture, Fisheries and Food.

Commenting on the announcement, Owen Killian, Chairman said: 'Following on from our recent announcement in relation to the appointment of Gary Britton and Rose Hynes, I am now delighted to also welcome Kate and Christopher to the Board of Origin. They bring along extensive experience in the UK food and agricultural sector and I look forward to their contribution to the enlarged Origin Board.'

Details of the directorships held by the new Non-Executive Directors within the past five years are set out at the end of this announcement.

There are no further details that are required to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM and ESM Rules.

 

ENDS

 

Enquiries:

 

Origin Enterprises plc

Imelda Hurley

Chief Financial Officer Tel: +353 (0)1 612 1259

 

Goodbody (ESM Adviser)

Kevin Keating Tel: +353 (0)1 667 0420

 

Davy (Nominated Adviser)

Anthony Farrell Tel: +353 (0)1 614 9993

 

Murray Consultants

Douglas Keatinge Tel: +353 (0) 86 037 4163

 

 

About Origin Enterprises plc

 

Origin Enterprises plc is a focused Agri-Services group providing on-farm advice and the supply of agri-inputs. The Agri-Services business through its manufacturing and distribution operations in Ireland, the United Kingdom, Poland, Ukraine and Romania has leading market positions in the supply of specialist agronomy services, crop nutrition and feed ingredients. The Group is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

Details of Directorships held by the new Non-Executive Directors within the past five years.

 

Ms. Kate Allum

 

Current Directorships

Cranswick plc

 

Previous Directorships

First Milk Limited

 

 

Dr. Christopher Richards

 

Current Directorships

Ashridge Great Barn Limited

Dechra Pharmaceuticals plc

Plant Health Care plc

Richards Underwriting Limited

Talestris Limited

 

Previous Directorships

Arysta LifeScience European Investments Limited

Arysta LifeScience Global Limited

Arysta LifeScience U.K. Limited

Arysta LifeScience U.K. BRL Limited

Arysta LifeScience U.K. CAD Limited

Arysta LifeScience U.K. EUR Limited

Arysta LifeScience U.K. Holdings Limited

Arysta LifeScience U.K. JPY Limited

Arysta LifeScience U.K. USD Limited

Arysta LifeScience U.K. USD-2 Limited

Bio Products Laboratory Limited

Cibus Global, Ltd

Oxitec Limited

 

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUVVNRVOAKUAR
Date   Source Headline
11th Jun 20267:00 amRNSQ3 Trading Update
3rd Jun 20262:48 pmRNSRe-issue of Treasury Shares
2nd Jun 20267:00 amRNSChange of Nominated Adviser
15th May 20267:45 amRNSDirector Declaration
1st May 20268:56 amRNSBlock Listing Six Monthly Return
20th Apr 20266:30 pmRNSRe-issue of Treasury Shares
20th Mar 20267:00 amRNSAgreement to Acquire Clarendon Agricare
9th Mar 20262:19 pmRNSRe-issue of Treasury Shares
9th Mar 20262:19 pmRNSRe-issue of Treasury Shares
5th Mar 20262:07 pmRNSRe-issue of Treasury Shares
3rd Mar 20265:20 pmRNSHolding(s) in Company
3rd Mar 20264:50 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:43 pmRNSDirector/PDMR Shareholding
3rd Mar 202611:13 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSInterim Results Statement
20th Feb 20262:35 pmRNSRe-issue of Treasury Shares
10th Feb 20267:00 amRNSCurrency Change
28th Jan 20264:08 pmRNSHolding(s) in Company
26th Jan 20265:14 pmRNSHolding(s) in Company
22nd Jan 20264:02 pmRNSRe-issue of Treasury Shares
20th Jan 20262:02 pmRNSRe-issue of Treasury Shares
16th Jan 20264:45 pmRNSRe-issue of Treasury Shares
12th Jan 20261:22 pmRNSRe-issue of Treasury Shares
19th Dec 20257:00 amRNSBoard Committee Membership Update
19th Dec 20257:00 amRNSBoard Committee Membership Update
16th Dec 202512:12 pmRNSRe-issue of Treasury Shares
15th Dec 20251:20 pmRNSRe-issue of Treasury Shares
5th Dec 20253:49 pmRNSRe-issue of Treasury Shares
1st Dec 202512:55 pmRNSRe-issue of Treasury Shares
26th Nov 202510:57 amRNSHolding(s) in Company
25th Nov 20252:41 pmRNSRe-issue of Treasury Shares
21st Nov 202510:26 amRNSRe-issue of Treasury Shares
20th Nov 20254:22 pmRNSAGM
20th Nov 20257:00 amRNSQ1 Trading Update
14th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 202510:00 amRNSAppointment of Chair Designate
3rd Nov 20257:00 amRNSBlock Listing Six Monthly Return
24th Oct 20253:52 pmRNSPosting of 2025 Annual Report and Notice of AGM
24th Oct 202510:30 amRNS2025 Annual Report and Sustainability Report
21st Oct 202512:39 pmRNSRe-issue of Treasury Shares
20th Oct 20251:08 pmRNSRe-issue of Treasury Shares
20th Oct 202512:44 pmRNSHolding(s) in Company
17th Oct 202512:56 pmRNSRe-issue of Treasury Shares
15th Oct 202512:48 pmRNSRe-issue of Treasury Shares
14th Oct 202511:20 amRNSRe-issue of Treasury Shares
13th Oct 202511:31 amRNSRe-issue of Treasury Shares
10th Oct 20252:32 pmRNSRe-issue of Treasury Shares
9th Oct 202512:02 pmRNSRe-issue of Treasury Shares
8th Oct 20252:30 pmRNSRe-issue of Treasury Shares
6th Oct 202511:54 amRNSRe-issue of Treasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.